BioRestorative Therapies, Inc. — Investor Relations & Filings
Filings indexed
721
across all filing types
Latest filing
2026-05-01
Regulatory Filings
Country
US
United States of America
Listing
US
BRTX
BioRestorative Therapies, Inc. is a clinical-stage biotechnology company focused on developing regenerative medicine products and cell-based therapies. The company utilizes adult stem cells to address unmet medical needs, primarily in degenerative disc disease and metabolic disorders. Its lead clinical program, BRTX-100, is an autologous stem cell therapy for chronic lumbar disc disease currently in a Phase 2 clinical trial. Another development program, ThermoStem, uses brown adipose-derived stem cells to target metabolic conditions. In addition to its therapeutic pipeline, the company has a BioCosmeceutical platform that develops biologics based on secretome technology, including exosomes and growth factors, for aesthetic medicine applications.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - BioRestorative Therapies, Inc. (0001505497) (Filer) | 2026-05-01 | English | |
| DEF 14A - BioRestorative Therapies, Inc. (0001505497) (Filer) | 2026-04-13 | English | |
| 10-K - BioRestorative Therapies, Inc. (0001505497) (Filer) | 2026-03-26 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| 8-K - BIORESTORATIVE THERAPIES, INC. (0001505497) (Filer) | 2026-02-14 | English | |
| 424B4 Filing | 2026-02-13 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 39622419 | 8-K - BioRestorative Therapies, Inc. (0001505497) (Filer) | 2026-05-01 | English | ||
| 34443122 | DEF 14A - BioRestorative Therapies, Inc. (0001505497) (Filer) | 2026-04-13 | English | ||
| 33052107 | 10-K - BioRestorative Therapies, Inc. (0001505497) (Filer) | 2026-03-26 | English | ||
| 30206148 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32892862 | 8-K - BIORESTORATIVE THERAPIES, INC. (0001505497) (Filer) | 2026-02-14 | English | ||
| 30206157 | 424B4 Filing | 2026-02-13 | English | ||
| 30206153 | S-1/A Filing | 2026-02-10 | English | ||
| 18535208 | S-1 - BioRestorative Therapies, Inc. (0001505497) (Filer) | 2026-02-09 | English | ||
|
2025
7 filings
| |||||
| 12404489 | Major Shareholding Notification 2025 | 2025-12-19 | English | ||
| 12404491 | PROSPECTUS RE 508,592 SHARES OF COMMON STOCK | 2025-12-12 | English | ||
| 12404493 | Regulatory Filings 2025 | 2025-12-11 | English | ||
| 12404492 | S-8 | 2025-11-18 | English | ||
| 12404494 | S-1 | 2025-11-18 | English | ||
| 12404495 | 10-Q | 2025-11-12 | English | ||
| 12404496 | THIRD QUARTER 2025 FINANCIAL RESULTS | 2025-11-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
BioRestorative Therapies, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35162/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35162 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35162 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35162 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35162}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BioRestorative Therapies, Inc. (id: 35162)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.